Enzo Biochem Inc (ENZ) — Strategic Asset Allocation Index
Enzo Biochem Inc (ENZ) has a Strategic Asset Allocation Index of 22.2% as of October 2023. Strategic assets (PP&E of $16.48 Million plus long-term investments of $-) total $16.48 Million, measured against net assets of $74.28 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Enzo Biochem Inc Strategic Asset Allocation Index (2000–2023)
This chart shows how Enzo Biochem Inc's Strategic Asset Allocation Index has evolved across 24 annual periods from 2000 to 2023. As of October 2023, the index stands at 22.2%, representing strategic assets of $16.48 Million against net assets of $74.28 Million USD. Explore ENZ cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Enzo Biochem Inc (2000–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Enzo Biochem Inc from 2000 to 2023, covering 24 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Enzo Biochem Inc (ENZ) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 21.3% | $16.71 Million | $16.71 Million | $- | $78.46 Million | ▼ -10.4 pp |
| 2022 | 31.7% | $17.26 Million | $17.26 Million | $- | $54.46 Million | ▼ -17.3 pp |
| 2021 | 49.0% | $33.60 Million | $33.60 Million | $- | $68.59 Million | ▲ +24.2 pp |
| 2020 | 24.8% | $14.48 Million | $14.48 Million | $- | $58.38 Million | ▲ +8.2 pp |
| 2019 | 16.6% | $14.25 Million | $14.25 Million | $- | $86.03 Million | ▲ +7.2 pp |
| 2018 | 9.4% | $7.64 Million | $7.64 Million | $- | $81.12 Million | ▲ +0.5 pp |
| 2017 | 8.9% | $7.90 Million | $7.90 Million | $- | $88.87 Million | ▼ -0.3 pp |
| 2016 | 9.2% | $8.21 Million | $8.21 Million | $- | $89.55 Million | ▼ -9.5 pp |
| 2015 | 18.7% | $7.95 Million | $7.95 Million | $- | $42.61 Million | ▼ -2.3 pp |
| 2014 | 20.9% | $7.73 Million | $7.73 Million | $- | $36.95 Million | ▼ -4.3 pp |
| 2013 | 25.2% | $8.62 Million | $8.62 Million | $- | $34.13 Million | ▲ +6.7 pp |
| 2012 | 18.6% | $9.12 Million | $9.12 Million | $- | $49.10 Million | ▲ +6.9 pp |
| 2011 | 11.6% | $10.34 Million | $10.34 Million | $- | $88.72 Million | ▼ -0.6 pp |
| 2010 | 12.2% | $11.86 Million | $11.86 Million | $- | $97.02 Million | ▲ +2.5 pp |
| 2009 | 9.7% | $11.32 Million | $11.32 Million | $- | $116.78 Million | ▲ +3.1 pp |
| 2008 | 6.5% | $9.05 Million | $9.05 Million | $- | $138.29 Million | ▲ +1.9 pp |
| 2007 | 4.7% | $6.62 Million | $6.62 Million | $- | $141.89 Million | ▼ -1.5 pp |
| 2006 | 6.1% | $5.85 Million | $5.85 Million | $- | $95.59 Million | ▲ +3.7 pp |
| 2005 | 2.5% | $2.67 Million | $2.67 Million | $- | $108.27 Million | ▲ +0.1 pp |
| 2004 | 2.3% | $2.42 Million | $2.42 Million | $- | $104.17 Million | ▲ +0.3 pp |
| 2003 | 2.0% | $2.20 Million | $2.20 Million | $- | $109.38 Million | ▼ -0.2 pp |
| 2002 | 2.2% | $2.30 Million | $2.30 Million | $- | $104.73 Million | ▼ -0.5 pp |
| 2001 | 2.7% | $2.67 Million | $2.67 Million | $- | $97.52 Million | ▼ -0.5 pp |
| 2000 | 3.2% | $2.80 Million | $2.80 Million | $- | $87.18 Million | — |